Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.
about
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadInhaled Antibiotics for Gram-Negative Respiratory InfectionsComparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats.New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin.Mechanism-based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models.Gelofusine Ameliorates Colistin-Induced Nephrotoxicity.Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
P2860
Q26822988-A92CF22F-47FD-49EC-868A-F7DAEEA84B39Q28386160-A9781A13-9BDE-47B1-B654-EA75614599FAQ34597749-59F4B0D6-CB07-4FD7-8406-A5C938BED456Q37538748-E3A2241B-F31F-4D8F-A69C-0E36480F8DC6Q37713056-686D731A-F4F3-40CF-A335-1616ACC6C47EQ38755683-A5E5E084-6E3C-4CA2-94E3-91A3FD1CC3E2Q39057108-C02AB098-1D5F-4D33-AE98-560D681B0DF1Q39333751-E46AFCD8-978B-4948-B60B-19A1C71A7969Q40093588-82DD9E67-F3AB-48F3-BD00-7CE49A5998D7Q41027375-7D87C65E-D65C-4B9C-82B6-C81ED5E02BAFQ41830402-FD843B88-7FF8-4ACB-A12A-61E90897A920Q47273930-A236C3F8-044B-4F9A-B6DD-88AC4E4F3063Q47327699-D1ECFC16-D73C-4B80-9630-1D3B3747A6DAQ47391725-E1D262EA-CCF9-4112-B190-79B79E78A2E3Q50035129-2F823FF3-B7C9-46BF-ABCB-283654E34008Q53217740-8D7483E3-0E8F-4CE5-9BC5-67BD0D994C07
P2860
Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Population pharmacokinetics of ...... geting respiratory infections.
@en
Population pharmacokinetics of ...... geting respiratory infections.
@nl
type
label
Population pharmacokinetics of ...... geting respiratory infections.
@en
Population pharmacokinetics of ...... geting respiratory infections.
@nl
prefLabel
Population pharmacokinetics of ...... geting respiratory infections.
@en
Population pharmacokinetics of ...... geting respiratory infections.
@nl
P2860
P50
P356
P1476
Population pharmacokinetics of ...... rgeting respiratory infections
@en
P2093
Kashyap Patel
Shalini Yapa
P2860
P304
P356
10.1128/AAC.01127-13
P407
P577
2013-08-05T00:00:00Z